Sean Sheridan is presenting the results of the valuation section of the “Global Life Sciences Royalty Rates & Deal Terms Survey” during the Life Sciences Sector lunch and business meeting.
For more information on this event, click here.
A look at Chinese courts’ new approach to IP damages
In this Law360 article, Fei Deng, Hong Qiao, and Yi Cheng examine the trend of Chinese courts toward awarding larger non-statutory damage awards in IP cases....